| Name | Title | Contact Details |
|---|
Phoenix Flavors & Fragrances is a leading developer and manufacturer of customized flavors and fragrances, with over two decades of experience in the industry. The company is dedicated to delivering high-quality, artisanal products that help clients innovate and stay competitive. Phoenix collaborates closely with its customers to create bespoke solutions, ensuring that each product meets the highest standards of quality and performance. Based in New Jersey, Phoenix employs between 501 and 1000 people and has a strong regulatory team and advanced quality assurance laboratories. This enables the company to maintain compliance with industry regulations and adapt to changing consumer preferences. In 2022, Phoenix expanded its capabilities by acquiring Innovative Fragrances, enhancing its offerings in the home fragrance, personal care, candles, and air fresheners markets. The company serves a diverse range of brands across various sectors, including food, beverages, and personal care.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
At SIS, were proud to be leaders in collecting, analyzing and distributing the deepest data sets and insights to professional sports teams across MLB, NBA and NFL, while also partnering extensively with the leagues themselves. Our mission is to enrich and optimize the decision-making process for sports teams, sportsbooks, and sports fans. Our vision is to create an unparalleled platform of sporting data and insights through best-in-class technology, products, and partnerships. Our versatility, subject matter expertise, and desire to enhance our partners performance is at the core of what we do. As we enter the next chapter of our trajectory, we are keen to put our data and newfound products to use to improve the sports fan experience, while being a critical part of the supply chain. Our existing database offers unparalleled detail and is updated daily, not just for the 3 professional sports listed, but at the collegiate, international and minor league levels as well. We are also moving further into the real-time data space (for the above noted sports) and into new sports/leagues. A key differentiator for us relative to competition is our flexibility and ability to customize feeds, data points, etc based on specific needs of partners. Company chairman John Dewan founded the company with a group of partners in 2003. John has been a pioneer in sports statistics for more than 40 years and was the founder of STATS Inc. In April of 2021, Audeo Capital announced a significant investment into SIS. Shortly thereafter, a new CEO (Dan Hannigan-Daley) and VP of Product/Engineering (Will Hester) joined the organization following years of success at DraftKings.
Connected Risk Solutions is a suite of wholesale specialists designed to connect our agency partners with the expertise and products needed to propel new business success and best serve clients with complex risks. We provide insurance information and programs to those who serve the healthcare industry, the professional liability needs of real estate firms, and the ever-growing need for cyber insurance across a wide range of industries. Our team of experts knows what agents expect and have built that knowledge into every part of the process. Highland Risk Services is one of the largest wholesale brokers producing insurance for retail agents who specialize in healthcare facilities. In addition to providing the professional and general liability coverage, we also offer work comp solutions to our agents using one of our premier programs. We are here to make you competitive and successful! If you need a broker that can make deals happen - call Highland Risk today!